Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases

  1. Yanxia Bi
  2. Jian Su
  3. Shengru Zhou
  4. Yingjie Zhao
  5. Yan Zhang
  6. Huihui Zhang
  7. Mingdong Liu
  8. Aiwu Zhou
  9. Jianrong Xu
  10. Meng Pan  Is a corresponding author
  11. Yiming Zhao  Is a corresponding author
  12. Fubin Li  Is a corresponding author
  1. Shanghai Jiao Tong University, China
  2. First Affiliated Hospital of Soochow University, China

Abstract

IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.

Data availability

All data and materials generated or analyzed during this study are either included in this manuscript (Figures and supplementary information) or available upon reasonable request.

Article and author information

Author details

  1. Yanxia Bi

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    Yanxia Bi, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..
  2. Jian Su

    Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  3. Shengru Zhou

    Department of Dermatology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    No competing interests declared.
  4. Yingjie Zhao

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    No competing interests declared.
  5. Yan Zhang

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    Yan Zhang, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..
  6. Huihui Zhang

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    Huihui Zhang, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..
  7. Mingdong Liu

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    No competing interests declared.
  8. Aiwu Zhou

    Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    No competing interests declared.
  9. Jianrong Xu

    Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, Shanghai, China
    Competing interests
    No competing interests declared.
  10. Meng Pan

    Department of Dermatology, Shanghai Jiao Tong University, Shanghai, China
    For correspondence
    pm10633@rjh.com.cn
    Competing interests
    No competing interests declared.
  11. Yiming Zhao

    Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China
    For correspondence
    zhaoyimingbox@163.com
    Competing interests
    No competing interests declared.
  12. Fubin Li

    Shanghai Institute of Immunology, Shanghai Jiao Tong University, Shanghai, China
    For correspondence
    fubin.li@sjtu.edu.cn
    Competing interests
    Fubin Li, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6268-3378

Funding

National Natural Science Foundation of China (31422020)

  • Fubin Li

National Natural Science Foundation of China (31870924)

  • Fubin Li

National Natural Science Foundation of China (81873431)

  • Yiming Zhao

Jiangsu Provincial Natural Science Foundation (BK20181164.)

  • Yiming Zhao

Shanghai Sailing Program (16YF1409700)

  • Yan Zhang

Shanghai Municipal Natural Science Foundation project (15ZR1436400)

  • Huihui Zhang

Shanghai Young Oriental scholar program 2015

  • Huihui Zhang

Innovative research team of high-level local universities in Shanghai (SSMU-2DCX20180100)

  • Yan Zhang
  • Huihui Zhang
  • Fubin Li

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mice were bred and maintained under specific pathogen-free (SPF) conditions, and all animal experiments were performed under the institutional guidelines of the Shanghai Jiao Tong University School of Medicine Institutional Animal Care and Use Committee (Protocol Registry Number: A-2015-014).

Human subjects: Ethical approval was obtained from the Ethics Committees in The Rui Jin Hospital of Shanghai Jiao Tong University School of Medicine and The First Affiliated Hospital of Soochow University, respectively. All PF and TTP patients and healthy volunteers signed informed consent.

Copyright

© 2022, Bi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,390
    views
  • 293
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yanxia Bi
  2. Jian Su
  3. Shengru Zhou
  4. Yingjie Zhao
  5. Yan Zhang
  6. Huihui Zhang
  7. Mingdong Liu
  8. Aiwu Zhou
  9. Jianrong Xu
  10. Meng Pan
  11. Yiming Zhao
  12. Fubin Li
(2022)
Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
eLife 11:e76223.
https://doi.org/10.7554/eLife.76223

Share this article

https://doi.org/10.7554/eLife.76223

Further reading

    1. Immunology and Inflammation
    Matteo Napoli, Roland Immler ... Monika Pruenster
    Research Article

    S100A8/A9 is an endogenous alarmin secreted by myeloid cells during many acute and chronic inflammatory disorders. Despite increasing evidence of the proinflammatory effects of extracellular S100A8/A9, little is known about its intracellular function. Here, we show that cytosolic S100A8/A9 is indispensable for neutrophil post-arrest modifications during outside-in signaling under flow conditions in vitro and neutrophil recruitment in vivo, independent of its extracellular functions. Mechanistically, genetic deletion of S100A9 in mice caused dysregulated Ca2+ signatures in activated neutrophils resulting in reduced Ca2+ availability at the formed LFA-1/F-actin clusters with defective β2 integrin outside-in signaling during post-arrest modifications. Consequently, we observed impaired cytoskeletal rearrangement, cell polarization, and spreading, as well as cell protrusion formation in S100a9-/- compared to wildtype (WT) neutrophils, making S100a9-/- cells more susceptible to detach under flow, thereby preventing efficient neutrophil recruitment and extravasation into inflamed tissue.

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Lucia Csepregi, Kenneth Hoehn ... Sai T Reddy
    Research Article

    Diverse antibody repertoires spanning multiple lymphoid organs (i.e., bone marrow, spleen, lymph nodes) form the foundation of protective humoral immunity. Changes in their composition across lymphoid organs are a consequence of B-cell selection and migration events leading to a highly dynamic and unique physiological landscape of antibody repertoires upon antigenic challenge (e.g., vaccination). However, to what extent B cells encoding identical or similar antibody sequences (clones) are distributed across multiple lymphoid organs and how this is shaped by the strength of a humoral response remains largely unexplored. Here, we performed an in-depth systems analysis of antibody repertoires across multiple distinct lymphoid organs of immunized mice and discovered that organ-specific antibody repertoire features (i.e., germline V-gene usage and clonal expansion profiles) equilibrated upon a strong humoral response (multiple immunizations and high serum titers). This resulted in a surprisingly high degree of repertoire consolidation, characterized by highly connected and overlapping B-cell clones across multiple lymphoid organs. Finally, we revealed distinct physiological axes indicating clonal migrations and showed that antibody repertoire consolidation directly correlated with antigen specificity. Our study uncovered how a strong humoral response resulted in a more uniform but redundant physiological landscape of antibody repertoires, indicating that increases in antibody serum titers were a result of synergistic contributions from antigen-specific B-cell clones distributed across multiple lymphoid organs. Our findings provide valuable insights for the assessment and design of vaccine strategies.